| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| TRPM Cation Channels | 18 | 2018 | 35 | 5.790 |
Why?
|
| Neurons | 43 | 2020 | 1130 | 4.650 |
Why?
|
| Sodium Channels | 21 | 2018 | 63 | 3.920 |
Why?
|
| Nerve Tissue Proteins | 21 | 2012 | 338 | 3.810 |
Why?
|
| Brain Ischemia | 23 | 2019 | 179 | 3.640 |
Why?
|
| Stroke | 11 | 2024 | 274 | 3.170 |
Why?
|
| Acidosis | 14 | 2020 | 49 | 2.890 |
Why?
|
| Calcium | 27 | 2018 | 445 | 2.680 |
Why?
|
| Cerebral Cortex | 16 | 2020 | 274 | 2.510 |
Why?
|
| Membrane Potentials | 15 | 2016 | 213 | 2.300 |
Why?
|
| Zinc | 8 | 2015 | 114 | 2.050 |
Why?
|
| Membrane Proteins | 12 | 2008 | 486 | 1.870 |
Why?
|
| Animals | 76 | 2024 | 14307 | 1.740 |
Why?
|
| Mice | 46 | 2024 | 5668 | 1.620 |
Why?
|
| Signal Transduction | 9 | 2020 | 1802 | 1.360 |
Why?
|
| Cell Movement | 4 | 2015 | 545 | 1.310 |
Why?
|
| Brain Injuries | 4 | 2024 | 104 | 1.260 |
Why?
|
| Cells, Cultured | 25 | 2017 | 1442 | 1.220 |
Why?
|
| Cell Proliferation | 6 | 2019 | 1149 | 1.140 |
Why?
|
| Nerve Degeneration | 5 | 2011 | 101 | 1.050 |
Why?
|
| Patch-Clamp Techniques | 16 | 2016 | 214 | 1.030 |
Why?
|
| CHO Cells | 14 | 2023 | 107 | 0.980 |
Why?
|
| Neuroprotective Agents | 8 | 2015 | 231 | 0.980 |
Why?
|
| Brain | 13 | 2024 | 1268 | 0.950 |
Why?
|
| Cricetulus | 14 | 2023 | 74 | 0.940 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2020 | 109 | 0.940 |
Why?
|
| Lidocaine | 2 | 2014 | 15 | 0.910 |
Why?
|
| Ion Channel Gating | 5 | 2018 | 81 | 0.880 |
Why?
|
| Amiloride | 5 | 2016 | 16 | 0.870 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 90 | 0.850 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2020 | 32 | 0.840 |
Why?
|
| Glucose | 6 | 2018 | 217 | 0.830 |
Why?
|
| Cell Membrane Permeability | 2 | 2015 | 49 | 0.810 |
Why?
|
| Protein Kinase C | 2 | 2020 | 110 | 0.760 |
Why?
|
| MAP Kinase Signaling System | 4 | 2020 | 162 | 0.740 |
Why?
|
| Neurites | 2 | 2017 | 35 | 0.740 |
Why?
|
| Cricetinae | 13 | 2023 | 217 | 0.730 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 1530 | 0.730 |
Why?
|
| Osteosarcoma | 1 | 2019 | 24 | 0.720 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 28 | 0.720 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 180 | 0.710 |
Why?
|
| Hydrogen-Ion Concentration | 12 | 2016 | 342 | 0.710 |
Why?
|
| Reducing Agents | 2 | 2016 | 13 | 0.670 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2019 | 229 | 0.670 |
Why?
|
| Infarction, Middle Cerebral Artery | 7 | 2020 | 76 | 0.670 |
Why?
|
| Glutamic Acid | 4 | 2015 | 115 | 0.650 |
Why?
|
| Lysosomes | 1 | 2018 | 80 | 0.640 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 781 | 0.640 |
Why?
|
| NF-kappa B | 1 | 2020 | 306 | 0.630 |
Why?
|
| Estradiol | 1 | 2019 | 244 | 0.620 |
Why?
|
| Calcium Channels | 3 | 2015 | 72 | 0.620 |
Why?
|
| Smell | 1 | 2017 | 35 | 0.620 |
Why?
|
| RNA, Messenger | 9 | 2016 | 1152 | 0.610 |
Why?
|
| Autophagy | 1 | 2018 | 111 | 0.610 |
Why?
|
| RNA Interference | 5 | 2017 | 225 | 0.610 |
Why?
|
| Hippocampus | 8 | 2011 | 546 | 0.610 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 16 | 0.600 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2016 | 984 | 0.600 |
Why?
|
| Dithiothreitol | 1 | 2016 | 18 | 0.600 |
Why?
|
| Anesthetics, Local | 2 | 2014 | 21 | 0.600 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 247 | 0.590 |
Why?
|
| Humans | 43 | 2024 | 34853 | 0.590 |
Why?
|
| Brain Neoplasms | 2 | 2014 | 105 | 0.590 |
Why?
|
| RNA, Small Interfering | 8 | 2015 | 391 | 0.590 |
Why?
|
| Apoptosis | 4 | 2018 | 1317 | 0.580 |
Why?
|
| Transfection | 7 | 2017 | 496 | 0.580 |
Why?
|
| Ethanol | 1 | 2018 | 188 | 0.580 |
Why?
|
| Hydrogen Peroxide | 3 | 2020 | 181 | 0.570 |
Why?
|
| Receptors, Glutamate | 3 | 2011 | 26 | 0.570 |
Why?
|
| Neuroblastoma | 1 | 2017 | 128 | 0.560 |
Why?
|
| Immediate-Early Proteins | 1 | 2016 | 45 | 0.560 |
Why?
|
| Glucocorticoids | 1 | 2016 | 80 | 0.560 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 2128 | 0.540 |
Why?
|
| Ions | 4 | 2014 | 61 | 0.520 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 73 | 0.510 |
Why?
|
| Transcription Factors | 1 | 2019 | 653 | 0.510 |
Why?
|
| Extracellular Fluid | 4 | 2011 | 13 | 0.500 |
Why?
|
| Receptors, Notch | 1 | 2014 | 32 | 0.500 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 70 | 0.490 |
Why?
|
| Glioblastoma | 1 | 2014 | 49 | 0.490 |
Why?
|
| Sensory Receptor Cells | 1 | 2014 | 31 | 0.490 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 48 | 0.480 |
Why?
|
| Glioma | 1 | 2014 | 76 | 0.480 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 74 | 0.480 |
Why?
|
| Cell Adhesion | 1 | 2014 | 209 | 0.480 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 80 | 0.480 |
Why?
|
| Tetracaine | 1 | 2013 | 4 | 0.470 |
Why?
|
| Astrocytes | 2 | 2015 | 203 | 0.470 |
Why?
|
| Cell Differentiation | 1 | 2016 | 562 | 0.460 |
Why?
|
| Magnesium | 5 | 2014 | 95 | 0.460 |
Why?
|
| Hyperglycemia | 1 | 2013 | 53 | 0.450 |
Why?
|
| Male | 23 | 2021 | 18870 | 0.430 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 968 | 0.430 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 43 | 0.430 |
Why?
|
| Neurotoxins | 2 | 2010 | 52 | 0.420 |
Why?
|
| Radius Fractures | 2 | 2022 | 3 | 0.400 |
Why?
|
| Spider Venoms | 4 | 2017 | 7 | 0.400 |
Why?
|
| Nitric Oxide | 2 | 2013 | 287 | 0.400 |
Why?
|
| Central Nervous System | 1 | 2012 | 130 | 0.390 |
Why?
|
| Carboxypeptidase H | 4 | 2017 | 5 | 0.390 |
Why?
|
| Phosphorylation | 6 | 2015 | 878 | 0.380 |
Why?
|
| NAD | 1 | 2010 | 39 | 0.360 |
Why?
|
| Electric Stimulation | 4 | 2016 | 177 | 0.360 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2022 | 131 | 0.360 |
Why?
|
| Disease Models, Animal | 8 | 2016 | 1300 | 0.360 |
Why?
|
| Ion Channels | 2 | 2007 | 69 | 0.350 |
Why?
|
| Cell Line | 5 | 2020 | 1289 | 0.350 |
Why?
|
| Time Factors | 6 | 2020 | 1681 | 0.340 |
Why?
|
| Oxidation-Reduction | 5 | 2016 | 407 | 0.340 |
Why?
|
| Ischemia | 4 | 2022 | 45 | 0.340 |
Why?
|
| Electrophysiology | 6 | 2010 | 130 | 0.340 |
Why?
|
| Indoles | 3 | 2010 | 154 | 0.330 |
Why?
|
| N-Methylaspartate | 3 | 2022 | 55 | 0.330 |
Why?
|
| Calcium Signaling | 5 | 2014 | 95 | 0.320 |
Why?
|
| Rats | 18 | 2023 | 3261 | 0.320 |
Why?
|
| Up-Regulation | 4 | 2020 | 490 | 0.320 |
Why?
|
| Biophysics | 3 | 2016 | 36 | 0.310 |
Why?
|
| Models, Biological | 5 | 2021 | 642 | 0.310 |
Why?
|
| Protein Binding | 5 | 2019 | 913 | 0.310 |
Why?
|
| Mice, Knockout | 10 | 2020 | 897 | 0.310 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 73 | 0.300 |
Why?
|
| Base Sequence | 4 | 2019 | 932 | 0.300 |
Why?
|
| Beauveria | 1 | 2006 | 1 | 0.300 |
Why?
|
| Androstenedione | 1 | 2006 | 16 | 0.300 |
Why?
|
| Carcinoma | 1 | 2007 | 94 | 0.300 |
Why?
|
| Oxidative Stress | 3 | 2020 | 874 | 0.290 |
Why?
|
| Down-Regulation | 2 | 2019 | 420 | 0.280 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 119 | 0.280 |
Why?
|
| Models, Neurological | 1 | 2007 | 123 | 0.280 |
Why?
|
| Endothelial Cells | 1 | 2009 | 296 | 0.280 |
Why?
|
| Cyclic AMP | 2 | 2017 | 125 | 0.280 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2024 | 84 | 0.270 |
Why?
|
| Water Pollutants | 1 | 2005 | 17 | 0.260 |
Why?
|
| Peptides | 3 | 2017 | 308 | 0.260 |
Why?
|
| Ubiquitin | 2 | 2020 | 76 | 0.260 |
Why?
|
| Butadienes | 3 | 2020 | 30 | 0.260 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 161 | 0.260 |
Why?
|
| Nitriles | 3 | 2020 | 66 | 0.250 |
Why?
|
| Organometallic Compounds | 1 | 2005 | 68 | 0.250 |
Why?
|
| Latent Tuberculosis | 1 | 2024 | 2 | 0.250 |
Why?
|
| Phenols | 1 | 2005 | 76 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 605 | 0.240 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2023 | 20 | 0.240 |
Why?
|
| Fracture Fixation, Internal | 2 | 2022 | 7 | 0.240 |
Why?
|
| Gene Silencing | 2 | 2015 | 143 | 0.240 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2023 | 3 | 0.230 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2003 | 14 | 0.230 |
Why?
|
| Blotting, Western | 3 | 2015 | 834 | 0.230 |
Why?
|
| Tuberculosis | 1 | 2024 | 56 | 0.230 |
Why?
|
| Radius | 1 | 2022 | 1 | 0.220 |
Why?
|
| Boron Compounds | 2 | 2014 | 17 | 0.220 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2021 | 2 | 0.210 |
Why?
|
| Female | 10 | 2021 | 19873 | 0.210 |
Why?
|
| Meningitis, Bacterial | 1 | 2021 | 8 | 0.210 |
Why?
|
| Light | 2 | 2016 | 180 | 0.210 |
Why?
|
| Immunologic Memory | 1 | 2021 | 38 | 0.210 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2013 | 63 | 0.200 |
Why?
|
| Cell Death | 6 | 2008 | 260 | 0.200 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 102 | 0.200 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2020 | 39 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2023 | 137 | 0.190 |
Why?
|
| Molecular Sequence Data | 4 | 2016 | 1490 | 0.190 |
Why?
|
| Cysteine | 3 | 2011 | 88 | 0.190 |
Why?
|
| Naphthalenes | 1 | 2020 | 37 | 0.190 |
Why?
|
| Prognosis | 2 | 2019 | 707 | 0.190 |
Why?
|
| Carbazoles | 1 | 2020 | 43 | 0.190 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 69 | 0.180 |
Why?
|
| Bone Wires | 1 | 2019 | 1 | 0.180 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2019 | 4 | 0.180 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 123 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 528 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 638 | 0.170 |
Why?
|
| Protons | 2 | 2012 | 80 | 0.170 |
Why?
|
| Mice, Nude | 1 | 2019 | 323 | 0.170 |
Why?
|
| Transcription Factor CHOP | 1 | 2018 | 11 | 0.170 |
Why?
|
| Insulin | 2 | 2018 | 224 | 0.160 |
Why?
|
| Heat-Shock Proteins | 1 | 2018 | 51 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 91 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2020 | 117 | 0.160 |
Why?
|
| Renin | 1 | 2018 | 29 | 0.160 |
Why?
|
| Caspases | 1 | 2018 | 132 | 0.160 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 70 | 0.160 |
Why?
|
| Subcellular Fractions | 2 | 2016 | 72 | 0.160 |
Why?
|
| Gluconates | 1 | 2017 | 5 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 649 | 0.160 |
Why?
|
| Hyperaldosteronism | 1 | 2018 | 43 | 0.160 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 152 | 0.160 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2017 | 15 | 0.160 |
Why?
|
| Aldosterone | 1 | 2018 | 62 | 0.160 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 77 | 0.160 |
Why?
|
| Oxygen | 2 | 2010 | 193 | 0.150 |
Why?
|
| Receptor, trkB | 1 | 2017 | 14 | 0.150 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2017 | 6 | 0.150 |
Why?
|
| Enzyme Activation | 1 | 2018 | 423 | 0.150 |
Why?
|
| Cell Shape | 2 | 2014 | 35 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 87 | 0.150 |
Why?
|
| Thiazoles | 1 | 2017 | 71 | 0.150 |
Why?
|
| Reaction Time | 1 | 2017 | 130 | 0.150 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2016 | 3 | 0.150 |
Why?
|
| Amino Acid Sequence | 4 | 2016 | 1124 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 3 | 2007 | 71 | 0.150 |
Why?
|
| Dipeptides | 1 | 2017 | 29 | 0.150 |
Why?
|
| Intracellular Space | 2 | 2014 | 35 | 0.150 |
Why?
|
| Thionucleotides | 1 | 2016 | 8 | 0.150 |
Why?
|
| Propionates | 1 | 2016 | 25 | 0.150 |
Why?
|
| Cell Survival | 4 | 2014 | 818 | 0.140 |
Why?
|
| Hydrazines | 1 | 2016 | 21 | 0.140 |
Why?
|
| Adult | 5 | 2021 | 11034 | 0.140 |
Why?
|
| Dendrites | 3 | 2016 | 52 | 0.140 |
Why?
|
| Cholestanols | 1 | 2015 | 2 | 0.140 |
Why?
|
| Electric Conductivity | 2 | 2007 | 47 | 0.140 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 81 | 0.140 |
Why?
|
| Glutathione | 1 | 2016 | 160 | 0.140 |
Why?
|
| Neurogenesis | 1 | 2016 | 55 | 0.140 |
Why?
|
| Benzamides | 1 | 2016 | 76 | 0.140 |
Why?
|
| Necrosis | 1 | 2015 | 45 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 69 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 608 | 0.130 |
Why?
|
| Middle Cerebral Artery | 2 | 2012 | 16 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 105 | 0.130 |
Why?
|
| Myosin Light Chains | 1 | 2014 | 5 | 0.130 |
Why?
|
| Lysine | 2 | 2006 | 104 | 0.130 |
Why?
|
| Procaine | 1 | 2014 | 2 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 430 | 0.130 |
Why?
|
| Phosphotyrosine | 1 | 2014 | 24 | 0.130 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 11 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 484 | 0.130 |
Why?
|
| Analysis of Variance | 3 | 2011 | 528 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2019 | 386 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 245 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 66 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 185 | 0.120 |
Why?
|
| Electric Power Supplies | 1 | 2014 | 10 | 0.120 |
Why?
|
| Lithium | 1 | 2014 | 16 | 0.120 |
Why?
|
| Wound Healing | 1 | 2014 | 69 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 8 | 0.120 |
Why?
|
| Isoenzymes | 1 | 2014 | 149 | 0.120 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 30 | 0.120 |
Why?
|
| Phosphates | 1 | 2014 | 49 | 0.120 |
Why?
|
| Neuronal Plasticity | 1 | 2015 | 102 | 0.120 |
Why?
|
| Iron | 2 | 2014 | 204 | 0.120 |
Why?
|
| Middle Aged | 6 | 2021 | 9642 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 122 | 0.120 |
Why?
|
| China | 3 | 2021 | 178 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2017 | 418 | 0.120 |
Why?
|
| Ganglia, Spinal | 1 | 2013 | 36 | 0.110 |
Why?
|
| Graphite | 1 | 2014 | 50 | 0.110 |
Why?
|
| Baroreflex | 1 | 2012 | 9 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 416 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2012 | 4 | 0.110 |
Why?
|
| Models, Molecular | 1 | 2016 | 751 | 0.110 |
Why?
|
| Nanostructures | 1 | 2014 | 133 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2015 | 1534 | 0.110 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 91 | 0.100 |
Why?
|
| Trace Elements | 1 | 2011 | 25 | 0.100 |
Why?
|
| Permeability | 1 | 2011 | 67 | 0.100 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2010 | 8 | 0.100 |
Why?
|
| Guanidines | 1 | 2010 | 17 | 0.100 |
Why?
|
| Hypertension | 1 | 2018 | 770 | 0.100 |
Why?
|
| Spermine | 1 | 2011 | 64 | 0.100 |
Why?
|
| Amidines | 1 | 2010 | 3 | 0.090 |
Why?
|
| Sirtuins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Rodentia | 1 | 2010 | 41 | 0.090 |
Why?
|
| Rats, Wistar | 2 | 2007 | 202 | 0.090 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 34 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 72 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 2010 | 57 | 0.090 |
Why?
|
| Membrane Transport Modulators | 1 | 2009 | 4 | 0.090 |
Why?
|
| Synapses | 2 | 2008 | 173 | 0.090 |
Why?
|
| Species Specificity | 1 | 2010 | 233 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 383 | 0.090 |
Why?
|
| Animals, Newborn | 2 | 2008 | 323 | 0.090 |
Why?
|
| Antibodies, Viral | 2 | 2021 | 252 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 336 | 0.090 |
Why?
|
| Mutation | 3 | 2016 | 1023 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 101 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2011 | 92 | 0.090 |
Why?
|
| Dynorphins | 1 | 2009 | 14 | 0.090 |
Why?
|
| Proprotein Convertase 2 | 1 | 2009 | 16 | 0.090 |
Why?
|
| Sodium Channel Blockers | 2 | 2009 | 16 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2010 | 467 | 0.090 |
Why?
|
| Homeostasis | 1 | 2010 | 172 | 0.080 |
Why?
|
| Aged | 3 | 2021 | 6448 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2007 | 70 | 0.080 |
Why?
|
| Neuropeptides | 2 | 2009 | 57 | 0.080 |
Why?
|
| Corpus Striatum | 1 | 2009 | 99 | 0.080 |
Why?
|
| Calcium Channel Blockers | 2 | 2004 | 56 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2010 | 360 | 0.080 |
Why?
|
| Status Epilepticus | 1 | 2007 | 11 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2010 | 226 | 0.080 |
Why?
|
| Pyramidal Cells | 1 | 2008 | 60 | 0.080 |
Why?
|
| Protein Kinases | 2 | 2007 | 91 | 0.080 |
Why?
|
| Propidium | 1 | 2007 | 18 | 0.080 |
Why?
|
| Calcineurin | 1 | 2007 | 21 | 0.080 |
Why?
|
| Ischemic Preconditioning | 2 | 2008 | 48 | 0.080 |
Why?
|
| Shear Strength | 1 | 2007 | 23 | 0.080 |
Why?
|
| Sodium | 1 | 2007 | 101 | 0.080 |
Why?
|
| Epilepsy | 1 | 2007 | 41 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2008 | 65 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2007 | 51 | 0.080 |
Why?
|
| Organ Culture Techniques | 1 | 2007 | 99 | 0.080 |
Why?
|
| Sulfides | 1 | 2007 | 58 | 0.080 |
Why?
|
| Sodium Bicarbonate | 1 | 2006 | 8 | 0.080 |
Why?
|
| Kinetics | 2 | 2007 | 650 | 0.080 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 23 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 413 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 110 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2009 | 298 | 0.070 |
Why?
|
| Oxidants | 1 | 2006 | 43 | 0.070 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2006 | 68 | 0.070 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2006 | 75 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 112 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2021 | 1422 | 0.070 |
Why?
|
| Aluminum Silicates | 1 | 2005 | 6 | 0.070 |
Why?
|
| Binding Sites | 1 | 2007 | 597 | 0.070 |
Why?
|
| Aluminum | 1 | 2005 | 34 | 0.070 |
Why?
|
| Photochemistry | 1 | 2005 | 61 | 0.070 |
Why?
|
| Receptors, Glycine | 1 | 2004 | 7 | 0.060 |
Why?
|
| Water Purification | 1 | 2005 | 27 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 62 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 352 | 0.060 |
Why?
|
| Ventral Tegmental Area | 1 | 2004 | 36 | 0.060 |
Why?
|
| Neoplasms | 1 | 2014 | 1033 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 162 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2004 | 53 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2004 | 85 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 52 | 0.060 |
Why?
|
| Cocaine | 1 | 2006 | 219 | 0.060 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2023 | 9 | 0.060 |
Why?
|
| Hibernation | 1 | 2003 | 7 | 0.060 |
Why?
|
| Mitochondria | 1 | 2007 | 454 | 0.060 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2003 | 2 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2023 | 90 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2003 | 42 | 0.060 |
Why?
|
| Drug Design | 1 | 2004 | 154 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2023 | 92 | 0.060 |
Why?
|
| Kainic Acid | 2 | 2017 | 47 | 0.060 |
Why?
|
| Child | 2 | 2022 | 2875 | 0.060 |
Why?
|
| Diuretics | 1 | 2003 | 49 | 0.060 |
Why?
|
| Dopamine | 1 | 2004 | 232 | 0.060 |
Why?
|
| Arthrography | 1 | 2022 | 1 | 0.060 |
Why?
|
| Elbow | 1 | 2022 | 4 | 0.060 |
Why?
|
| Long-Term Potentiation | 2 | 2017 | 99 | 0.060 |
Why?
|
| Synaptic Transmission | 3 | 2010 | 141 | 0.060 |
Why?
|
| Glycine | 1 | 2022 | 44 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 286 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2022 | 115 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2021 | 18 | 0.050 |
Why?
|
| Convalescence | 1 | 2021 | 7 | 0.050 |
Why?
|
| Actins | 1 | 2022 | 142 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 46 | 0.050 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 27 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 197 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 2009 | 125 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 211 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 86 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2021 | 112 | 0.050 |
Why?
|
| Antigens, Bacterial | 1 | 2021 | 129 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2021 | 135 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 181 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2021 | 235 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 232 | 0.050 |
Why?
|
| Gene Expression | 1 | 2003 | 639 | 0.050 |
Why?
|
| Imidazoles | 1 | 2020 | 124 | 0.050 |
Why?
|
| Pyridines | 1 | 2020 | 113 | 0.050 |
Why?
|
| Extracellular Space | 2 | 2010 | 33 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1056 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 1007 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 608 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 341 | 0.040 |
Why?
|
| Automation, Laboratory | 1 | 2018 | 3 | 0.040 |
Why?
|
| Reperfusion | 2 | 2009 | 15 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2018 | 26 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 56 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2022 | 1349 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2022 | 1318 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 569 | 0.040 |
Why?
|
| Immunoassay | 1 | 2018 | 57 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2017 | 47 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 2017 | 54 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 58 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 964 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 60 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 555 | 0.040 |
Why?
|
| Reperfusion Injury | 2 | 2007 | 53 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2018 | 213 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2022 | 1961 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 85 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 92 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2016 | 156 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 26 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2333 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 901 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 16 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 376 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 281 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 162 | 0.030 |
Why?
|
| Porosity | 1 | 2014 | 32 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2014 | 22 | 0.030 |
Why?
|
| Electrodes | 1 | 2014 | 43 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 310 | 0.030 |
Why?
|
| Neostigmine | 1 | 2012 | 2 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 38 | 0.030 |
Why?
|
| Publication Bias | 1 | 2012 | 2 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 271 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2013 | 517 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 580 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2012 | 155 | 0.030 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2011 | 7 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 87 | 0.030 |
Why?
|
| Picrotoxin | 1 | 2011 | 10 | 0.030 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2011 | 4 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 641 | 0.030 |
Why?
|
| Tetrazolium Salts | 1 | 2011 | 36 | 0.030 |
Why?
|
| Putrescine | 1 | 2011 | 25 | 0.020 |
Why?
|
| Benzamidines | 1 | 2010 | 4 | 0.020 |
Why?
|
| GABA Antagonists | 1 | 2011 | 25 | 0.020 |
Why?
|
| Valine | 1 | 2011 | 31 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 48 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 89 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 168 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 59 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2011 | 137 | 0.020 |
Why?
|
| Histidine | 1 | 2010 | 36 | 0.020 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2010 | 2 | 0.020 |
Why?
|
| Diminazene | 1 | 2010 | 1 | 0.020 |
Why?
|
| Stilbamidines | 1 | 2010 | 1 | 0.020 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2010 | 6 | 0.020 |
Why?
|
| Silver Staining | 1 | 2010 | 7 | 0.020 |
Why?
|
| Pentamidine | 1 | 2010 | 9 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2010 | 73 | 0.020 |
Why?
|
| Zinc Compounds | 1 | 2009 | 12 | 0.020 |
Why?
|
| Oocytes | 1 | 2010 | 143 | 0.020 |
Why?
|
| Chlorides | 1 | 2009 | 52 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 5035 | 0.020 |
Why?
|
| Memory | 1 | 2010 | 165 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2008 | 14 | 0.020 |
Why?
|
| Gliosis | 1 | 2008 | 22 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4012 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2007 | 22 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 287 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 198 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2007 | 16 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 64 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2007 | 27 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 302 | 0.020 |
Why?
|
| Maze Learning | 1 | 2008 | 100 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 45 | 0.020 |
Why?
|
| Isoindoles | 1 | 2007 | 17 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 78 | 0.020 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2007 | 7 | 0.020 |
Why?
|
| Action Potentials | 1 | 2009 | 219 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 91 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2007 | 33 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 210 | 0.020 |
Why?
|
| Seizures | 1 | 2007 | 67 | 0.020 |
Why?
|
| Solvents | 1 | 2007 | 93 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 16 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 40 | 0.020 |
Why?
|
| Neostriatum | 1 | 2006 | 25 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 903 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 184 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 126 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2007 | 108 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 175 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 146 | 0.020 |
Why?
|
| Locomotion | 1 | 2006 | 91 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 310 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 485 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 396 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2008 | 287 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 859 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3414 | 0.020 |
Why?
|
| Glycine Agents | 1 | 2004 | 1 | 0.020 |
Why?
|
| Taurine | 1 | 2004 | 3 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 165 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2004 | 47 | 0.020 |
Why?
|
| Cell Separation | 1 | 2004 | 91 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 126 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2004 | 59 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2004 | 83 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 32 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2003 | 5 | 0.020 |
Why?
|
| Cations | 1 | 2003 | 44 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2003 | 34 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 298 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 455 | 0.010 |
Why?
|